On December 19, 2024, the US Food and Drug Administration (FDA) approved the expansion of the TRICAV I study for the TricValve® Transcatheter Bicaval Valve System* from 15 patients to 50 patients at a total of 50 sites in the United States via the Investigational

SINGAPORE – Patients with leaky heart valve have more minimally invasive options to treat the condition, after two new procedures were introduced at the National Heart Centre Singapore (NHCS). Also known as tricuspid regurgitation, the heart condition occurs when the valve between the two chambers

Vienna, Feburary 24th 2022 TricValve® Transcatheter Bicaval Valves System Today, P&F Products & Features GmbH announced that the first implantation of its breakthrough technology, the TricValve® Transcatheter Bicaval Valves System, was recently performed under the guidance of Samir Kapadia MD, Interventional Cardiologist and Chairman, Dept.